1Interactive Research School for Health Affairs (IRSHA), Bharati Vidyapeeth University Medical College Campus, Dhankawadi, Pune 411043, India, 2Natural Remedies Pvt. Ltd., Veersandra Industrial Area, 19 KM Hosur Road, Electronic City Post, Bangalore 560100, Karnataka, India, 3Bharati Vidyapeeth University Medical College, Dhankawadi, Pune 411043, India
Email: ruchika.kaulghanekar@gmail.com
Received: 19 Aug 2015 Revised and Accepted: 05 Oct 2015
ABSTRACT
Objectives: The objective of this research was to compare the anti-inflammatory activity of aqueous and methanolic extracts of C. cassia (CC)and C. zeylanicum (CZ) in mouse macrophage (RAW264.7) and human chondrosarcoma (SW1353) cell lines as well as in human primary chondrocytes, to correlate their efficacy in management of osteoarthritis (OA) related pathophysiology.
Methods: RAW264.7, SW1353 and human primary chondrocytes were pre-treated with aqueous extracts of C. cassia (CCW) and C. zeylanicum (CZW) and methanolic extracts of C. cassia (CCM) and C. zeylanicum (CZM) at various concentrations (0.1-100 µg/ml) for 1 h, followed by stimulation with LPS and IL-1β, respectively. The effectofCCM, CCW, CZM and CZW on the production of nitric oxide (NO) was evaluated by Griess reaction. Evaluation of prostaglandin E2 (PGE2) and leukotriene (LTB4) proteins was performed by EIA-Monoclonal based kits. The effect of these extracts on matrix metalloproteinase (MMPs-2, 9 and 13) levels was analyzed by SensoLyte® fluorimetric MMP assay kit.
Results: The methanolic extracts (CCM, CZM) of both the varieties of cinnamon were found to be more effective than the aqueous extracts in terms of PGE2, LTB4 and MMP inhibition. We found that in RAW 264.7, CCM and CZM decreased NO and PGE2 production by45.4%±8.6; 65.6%±5.7 and 79.8%±1.2; 95.9%±0.3, respectively. Similarly, in SW1353 and chondrocytes, CCM decreased PGE2 production by 68.8%±6.4;36.1%±9.5, respectively whereas CZM reduced PGE2 production by 70.2%±2.3; 52.3%±5.4, respectively. Moreover, in SW1353 and chondrocytes CCM decreased LTB4 production by 85.47%±3.03; 99.6%±0.2, respectively whereas CZM reduced LTB4 production by 67.5%±5.6; 75.6%±1.2, respectively. In chondrocytes both CCM and CZM significantly reduced the levels of MMP-2(55.7%±5.2; 73.1%±7.1), MMP-9 (57.5%±4.7; 74.5%±5.2) and MMP-13 (90.1%±2.6; 71.2%±12.5), respectively. However, on comparing the two species of cinnamon, C. zeylanicum was found to be more effective than C. cassia and thus could be considered for its potential therapeutic application in the management of inflammatory conditions associated with OA.
Conclusion: The present study would help in choosing better of the two species of cinnamon for their possible therapeutic application in the management of inflammatory condition associated with OA.
Keywords: C. cassia, C. zeylanicum, Inflammation, Osteoarthritis, Chondrocytes.
© 2016 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
Cinnamon is widely used as a culinary spice and flavoring agent [1]. It has been extensively used in Indian traditional medicine for the management of various disease conditions [2]. Various studies have shown that Cinnamon has anti-inflammatory properties and decreased the expression of the inflammatory markers such as interleukin (IL)-1β, IL-6 and Tumor necrosis factor (TNF)-α [3]. Although there are many types of Cinnamon, only four varieties that are used for commercial purposes include C. zeylanicum, C. cassia, C. saigon and C. korintje. C. cassia (CC), is widely used as traditional Chinese medicine for treating blood circulation disturbances, gastritis and inflammatory diseases [4]. It has been shown to have various pharmacological properties, such as antiulcerogenic [5], anti-inflammatory [6], antipyretic [7], antimicrobial [8], antidiabetic [9] and antitumor activity [10]. Cinnamaldehyde, the active component of cinnamon, has been reported to down regulate the production of major inflammatory mediators such as inducible nitric oxide synthase (iNOS), cyclooxygenase (COX)-2, nuclear factor kappa (NF-κB) in RAW264.7 cells [11, 12]. C. zeylanicum (CZ), has been used traditionally for its anti-diabetic [13], anti-nociceptive [14], astringent [15] and diuretic activities [15]. Procyanidine polyphenols, a compound extracted from CZ has been reported to regulate inflammation and arthritis [16]. Gunawardena et al., (2015) has recently demonstrated the anti-inflammatory activity of cinnamon (CZ and CC) extracts as well as its phytochemical compounds (E-cinnamaldehyde and o-methoxy cinnamaldehyde) in vitro [17]. Hong et al., (2012) demonstrated that administration of water extract of cinnamon in vivo decreased the serum levels of TNF-α and IL-6. At in vitro level, it was shown to decrease the expression of TNF-α, inhibit LPS-induced degradation of IκBα as well as activate JNK, p38 and ERK1/2 [18].
Although several studies have reported anti-inflammatory activity of cinnamon bark from either CCorCZ, however, their efficacy in the management of osteoarthritis (OA) associated pathophysiology has not been compared. In the present work, we have for the first time compared the effect of two varieties of cinnamon on modulation of NO, PGE2, LTB4 and MMP levels in human chondrocytic cell line (SW1353) and human primary chondrocytes. Such studies would help in selection of important medicinal plants that could be used for the prevention, cure and management of OA related pathogenesis. We found that compared to the aqueous extracts, the methanolic extract of C. cassia and C. zeylanicum significantly modulated NO, PGE2, LTB4 and MMP levels in the tested cells. However, CZ proved to exhibit higher efficacy than CC and thus could be explored in the management of OA.
The materials used in the study included DMEM, L-15 media, Hams F12, FBS, penicillin and streptomycin, lipopolysaccharide (LPS), IL-1β, dexamethasone, 1400W dihydrochloride and (3-4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) were purchased from Sigma-Aldrich (St. Louis, MO, USA), L-glutamine was purchased from Himedia Corporation, Mumbai, India). MMP kit was purchased from Cisbio, PGE2 and LTB4 kits were purchased from Cayman and tissue culture plasticware was purchased from BD Biosciences (San Diego, CA, USA).
The extracts of the barks of C. cassia and C. zeylanicum were procured from Natural Remedies, Pvt. Ltd. Bangalore. The plant materials were identified by National Institute of Science Communication and Information Resources (NISCAR), New Delhi and Dr. P. Santhan, in-house taxonomist, Pharmacognosy department, R&D center, Natural Remedies Pvt. Ltd, Bangalore, India. The barks were sundried and stored. Voucher specimens (NRPL-569 and 570) were deposited in the herbarium of Natural Remedies, Pvt. Ltd. Bangalore.
For the preparation of CCM and CZM, the coarsely powdered raw material (50 g) was extracted with methanol (~200 ml) under reflux at 70oC for 1h and the solvent was filtered. The remaining raw material was refluxed by adding 150 ml methanol for 1 h, repeated twice and again filtered. The liquid filtrate was combined and concentrated using rotavapor under vacuum to a thick paste at temperature NMT 60 oC and 10.0 g of crude extract was obtained. For the preparation of CCW and CZW, the coarsely powdered raw material (50 g) was mixed with water and extracted at 85 to 90oC (3 times each with 200 ml water for 1 h each wash) and filtered each time. The combined liquid filtrates were concentrated using rota vapor under vacuum to a thick paste at temperature NMT 60oC and 15.0 g of crude water extract was obtained [19].
The cell lines RAW264.7 and SW1353 were purchased from American Type Culture Collection (ATCC, USA). The cell lines were maintained in DMEM and L-15 media containing 2 mM L-glutamine, respectively, (Himedia Corporation, Mumbai, India) supplemented with 10% FBS (Sigma, St. Louis, MO, USA), 20Units/ml penicillin and 20 µg/ml streptomycin (Gibco BRL, USA). Human cartilage sample was obtained from the patient undergoing knee replacement surgery after approval from institutional ethics committee (IEC) of Bharati Vidyapeeth Medical College (Ref: BVDU/MC/55) and informed consent from the patient. Chondrocytes were prepared by the enzymatic digestion of cartilage with 0.25% collagen and plated (1 × 106 cells/ml) in 35 mm primaria coated culture dishes. The cells were cultured in DMEM: Hams (1:1) F12 containing 2 mM L-glutamine, 10% FBS, 100Units/ml penicillin and 100 µg/ml streptomycin and incubated in 5% CO2 incubator at 37 °C.
For cell viability assay, RAW264.7, SW1353 and human primary chondrocytes were seeded at a density of 5x105cells/ml in 96-well plates. The cells were treated with different concentrations (0-100 µg/ml) of CCM, CCW, CZM and CZW for 24 h. Cell viability was determined by MTT assay as described previously [20, 21].
For evaluating nitric oxide (NO) release, RAW 264.7 cells were seeded at a density of 5x105cells/ml in 96 well plate and allowed to adhere for 24 h. The cells were pre-treated with different concentrations (0-100 µg/ml) of CCM, CCW, CZM and CZW for 1h, followed by stimulation with 1 µg/ml of LPS for 18 h. The amount of nitrite released was measured as described previously [21].
For PGE2 and LTB4 assays, RAW 264.7 cells, SW1353 and human primary chondrocytes were seeded at a density of 5x105cells/ml in 96 well plate and allowed to adhere for 24 h. RAW 264.7 cells were pre-treated with CCM, CCW, CZM and CZW as described above. SW1353 and human chondrocytes were starved for 18 h in L-15 media containing 0.25% FBS and 1:1 DMEM/Hams F-12 respectively, prior to treatment with the test samples. The cells were pre-treated with different concentrations (0-100 µg/ml) of CCM, CCW, CZM and CZW followed by stimulation with 10 ng/ml of IL-1β for 18 h. PGE2 concentration was determined in the cell supernatants by using PGE2 EIA-Monoclonal based kits (Cayman Co., Ann Arbor, Mich., USA). LTB4 levels were determined in the supernatant by using LTB4 EIA-Monoclonal based kits, (Cayman Co., Ann Arbor, Mich., USA). For evaluating MMP levels, human chondrocytes were starved for 18 h and pre-treated with CCM, CCW, CZM and CZW as described above. MMPs (2, 9, and 13) were quantified in the supernatant by using commercial SensoLyte® 520 Generic MMP Activity Kit (Cysbio Anaspec Eurogentec group, USA).
For statistical analysis, all the experiments were performed in triplicates and the values have been presented as mean±SD. Differences among means were tested for statistical significance using one-way analysis of variance (ANOVA). For multiple comparisons,Tukeys test was used. The analyses were carried out using Graph-pad prism 5 software (San Diego, CA, USA). *p<0.05; **p<0.01; ***p<0.001 were considered to be statistically significant.
Raw264.7, SW1353 and human chondrocytes were treated with different concentrations of extracts (0-100 μg/ml) to test their effect on cell viability. CCM and CCW (table 1a); as well as CZM and CZW (table 1b) were found to be non-toxic to the cells, thereby suggesting them to be safe for use in further studies.
Table 1a: Effect of CCM and CCW on cell viability in RAW264.7, SW1353, human primary chondrocytes
CCM |
CCW |
|||||
Concentration of extracts (μg/ml) |
RAW264.7 |
SW1353 |
human primary chondrocytes |
RAW264.7 |
SW1353 |
primary human chondrocytes |
0.1 |
101.1±1.4 |
100.2±0.1 |
100.4±0.3 |
101.4±2.3 |
102.7±3.4 |
101.8±2.4 |
1 |
100.1±0.8 |
100.1±0.04 |
100.1±0.1 |
101.8±2.5 |
103.6±3.6 |
104.3±0.9 |
10 |
100.2±0.8 |
100.0±0.2 |
100.8±0.4 |
100.7±0.7 |
105.8±3.1 |
109.7±3.3 |
100 |
100.5±0.5 |
102.8±2.5 |
104.0±1.1 |
100.8±0.8 |
104.3±1.1 |
112.0±1.7 |
Values have been represented as mean±SD of three independent experiments.
Table 1b: Effect of CZM and CZW on cell viability in RAW264.7, SW1353, human primary chondrocytes
CZM |
CZW |
|||||
Concentration of extracts (μg/ml) |
RAW264.7 |
SW1353 |
human primary chondrocytes |
RAW264.7 |
SW1353 |
primary human chondrocytes |
0.1 |
100.1±0.1 |
100.0±0.01 |
100.4±0.4 |
102.1±1.4 |
101.06±1.4 |
100.05±0.04 |
1 |
100.7±0.9 |
102.1±1.3 |
102.0±0.5 |
104.6±0.9 |
101.04±0.1 |
101.6±0.6 |
10 |
101.8±1.9 |
101.8±1.9 |
110.2±2.2 |
106.8±2.1 |
105.06±2.0 |
108.02±0.7 |
100 |
105.4±4.3 |
104.3±0.5 |
118.6±0.8 |
109.9±0.7 |
105.6±0.7 |
115.5±1.1 |
Values have been represented as mean±SD of three independent experiments.
Raw264.7 cells were treated with different concentrations of CCM, CCW, CZM and CZW (0-100 µg/ml). A significant dose dependent decrease in nitrite production was observed with both the extracts as compared to LPS stimulated control cells. We found that at 100 µg/ml dose, CCM exhibited 45.4 % (p<0.001) decrease in NO levels compared to CCW (24.7 %; p<0.001) (table 2). At the same dose, CZM effectively reduced the NO levels by 65.6 % (p<0.001) compared to CZW (28.67 %; p<0.001) (table 2). The results showed that CCM and CZM effectively reduced NO levels compared to their respective aqueous extracts.
Table 2: Effect of CCW, CCM, CZW and CZM on NO levels in LPS stimulated RAW264.7
Concentration of extracts (μg/ml) |
CCW |
CCM |
CZW |
CZM |
% decrease in NO levels |
||||
0.1 |
5.2±4.5 |
5.7±4.9 |
7.4±3.8 |
14.8±8.4 |
1 |
11.5±5.4 |
9.5±3.8 |
14.9±9.2 |
19.7±4.5 |
10 |
12.7±9.1 |
23.1±6.9 |
18.4±7.1 |
48.3±7.6 |
100 |
24.7±6.1 |
45.4±8.6a |
28.7±6.7c |
65.6±5.7b |
Values have been represented as mean±SD of three independent experiments. Tukey's multiple comparisons test: ap<0.05 compared to CCW, bp<0.01 compared to CZW, bp<0.05 compared to “a”, cp>0.05 compared to CCW
We compared the effect of CCM, CCW, CZM and CZW on PGE2 levels in RAW264.7, SW1353 and primary human chondrocytes. Since the extracts induced maximum inhibition in the nitrite levels in RAW264.7 cells at 100µg/ml dose, this dose was selected for our further experiments. It was observed that at 100 µg/ml dose, CCM and CCW reduced the PGE2 production by 79.8 % (p<0.001) and 80.1 % (p<0.001), respectively in RAW264.7 cells. At the same dose, CZM reduced PGE2 levels by 95.9 % (p<0.001), compared to CZw (11.2 %) (table 3). Both the extracts of CC seemed to be equally effective in reducing PGE2 levels in RAW264.7 cells. In IL-1β stimulated SW1353 cells, at 100µg/ml dose, CCM significantly reduced PGE2 production by 68.8 % (p<0.001) compared to CCw (22.36 %; p<0.001) whereas CZM was found to decrease PGE2 production by 70.2 % (p<0.001) compared to CZw (59.93 %; p<0.001) (table 3). Interestingly, in human primary chondrocytes, the methanolic extracts of cinnamon reduced PGE2 levels more effectively compared to the aqueous extracts. At 100µg/ml dose, CCM reduced PGE2 production by 36.1 % (p<0.01), compared to CCW (6.7 %) whereas CZM decreased the PGE2 production by 52.3 % (p<0.001), compared to CZW (16.2%) (table 3). The data showed that CCM and CZM reduced PGE2 levels significantly in chondrocytic cell line and primary chondrocytes.
Table 3: Effect of CCW, CCM, CZW and CZM on PGE2 levels in RAW264.7, SW1353 cells and primary human chondrocytes
% decrease in PGE2 levels |
|||
Concentration of extracts (100μg/ml) |
RAW264.7 |
SW1353 |
primary human chondrocytes |
CCW |
80.1±3.8 |
22.4±20.7 |
6.7±4.2 |
CCM |
79.8±1.2a |
68.8±6.4d |
36.1±9.5g |
CZW |
11.2±11.6c |
59.9±4.8f |
16.2±3.7i |
CZM |
95.9±0.3b |
70.2±2.3e |
52.3±5.4h |
Values have been represented as mean±SD of three independent experiments. Tukey's multiple comparisons test: ap>0.05 compared to CCW, bp<0.001 compared to CZW, bp<0.001 compared to “a”, cp<0.001 compared to CCW, dp<0.05 compared to CCW, ep>0.05 compared to CZW, ep>0.05 compared to “d”, fp<0.05 compared to CCW, gp<0.05 compared to CCW, hp<0.05 compared to CZW, hp>0.05 compared to “g”, ip>0.05 compared to CCW
CCM, CCW, CZM and CZW were further compared for their potential to modulate IL-1β induced LTB4 production in SW1353 and human chondrocytes. In SW1353, at 100µg/ml dose, CCM reduced LTB4 levels by 85.5 % (p<0.001) compared to CCW (61.6 %; p<0.001) (table 4). At the same dose CZM reduced LTB4 by 67.5 % (p<0.001) as compared to CZW (26.8 %; p<0.001). In human primary chondrocytes, at 100µg/ml dose, both CCM and CCW significantly reduced the LTB4 levels by 99.6 % (p<0.001) and 90.27 % (p<0.001), respectively. On the other hand, CZM reduced LTB4 levels by 75.6 % (p<0.001) compared to CZW (48.8 %; p<0.001) (table 4). Thus, CCM and CZM showed more decrease in LTB4 production compared to the aqueous extracts.
Table 4: Effect of CCW, CCM, CZW and CZM on LTB4 levels in SW1353 cells and primary human chondrocytes
Concentration of extracts (100μg/ml) |
% Decrease in LTB4 levels |
|
SW1353 |
primary human chondrocytes |
|
CCW |
61.6±4.6 |
90.3±0.1 |
CCM |
85.5±3.0a |
99.6±0.2d |
CZW |
26.8±6.1c |
48.8±0.9f |
CZM |
67.5±5.6b |
75.6±1.2e |
Values have been represented as mean±SD of three independent experiments. Tukey's multiple comparisons test: ap<0.05 compared to CCW, bp<0.01 compared to CZW, bp>0.05 compared to “a”, cp<0.01 compared to CCW, dp<0.01 compared to CCW, ep<0.001 compared to CZW, ep<0.001 compared to “d”, fp<0.001 compared to CCW
We compared the effect of CCM, CCW and CZM, CZW on IL-1β induced MMP levels in primary chondrocytes. Compared to control stimulated cells, at 100µg/ml dose, CCM reduced MMP 2, 9 and 13 production by 55.7 % (p<0.001), 57.5 % (p<0.001) and 90.1 % (p<0.001), respectively. At the same dose, CCW reduced MMP 2, 9 and 13 production by 16.1 %, 59.5 % (p<0.001) and 41.5 % (p<0.001), respectively (table 5). Similarly, at 100µg/ml dose, CZM significantly decreased MMP 2, 9 and 13 production by 73.1 % (p<0.001), 39 % (p<0.001) and 71.2 % (p<0.001), respectively, whereas CZW reduced MMP 2, 9 and 13 production by 15.6 %, 6.4 % and 40.1 % (p<0.01), respectively, compared to the control cells (table 5). Altogether, the data showed that methanolic extracts significantly reduced MMP levels compared to the aqueous extracts, however with few exceptions.
The present study compared the anti-inflammatory activity of aqueous and methanolic extracts of C. cassia and C. zeylanicum in RAW264.7, SW1353 and human primary chondrocytes. We found that in LPS activated RAW264.7 cells, CCM, CZM attenuated NO release more significantly than CCW, CZW. NO is a signalling molecule implicated in a broad spectrum of pathophysiological processes such as inflammation, apoptosis, regulation of enzyme activity and gene expression [22]. In an earlier study, it had been reported that the water extract of CC could not inhibit LPS-induced NO production in RAW 264.7 cells at 100 µg/ml concentration [25]. Interestingly, we found that at 100 µg/ml dose, CCW significantly inhibited LPS-induced NO production in RAW 264.7 cells. The difference in these results could be attributed to the method of preparation of the extracts, source variation, time of collection of the material and so on that may affect the presence of phytoactives in the extract, which contribute to their biological activity. Elevated levels of NO have been reported to play a critical role in the aggravation of chronic inflammatory conditions such as osteoarthritis [22-24]. Therefore, reducing NO production would be an important therapeutic target in the development of anti-inflammatory agents.
Table 5: Effect of CCW, CCM, CZW and CZM on MMP levels in primary human chondrocytes
Concentration of extracts (100μg/ml) |
Primary human chondrocytes |
||
% decrease in MMP levels |
|||
MMP-2 |
MMP-9 |
MMP-13 |
|
CCW |
16.1±17.0 |
59.5±4.2 |
41.5±7.8 |
CCM |
55.7±5.2a |
57.5±4.7d |
90.1±2.6g |
CZW |
15.6±22.1c |
6.4±3.2f |
40.1±5.7i |
CZM |
73.1±7.1b |
74.5±5.2e |
71.2±12.5h |
Values have been represented as mean±SD of three independent experiments. Tukey's multiple comparisons test: ap>0.05 compared to CCW, bp>0.05 compared to CZW, bp>0.05 compared to “a”, cp>0.05 compared to CCW, dp>0.05 compared to CCW, ep<0.001 compared to CZW, ep>0.05 compared to “d”, fp<0.001 compared to CCW, gp<0.01 compared to CCW, hp>0.05 compared to CZW, hp>0.05 compared to “g”, ip>0.05 compared to CCW
It was further observed that CCM and CZM effectively decreased PGE2 production in RAW264.7, SW1353 and human primary chondrocytes compared to the aqueous extracts. However, CZM was found to be more effective than CC in reducing PGE2 production. PGE2 is an important inflammatory mediator and is produced from arachidonic acid metabolites by the catalysis of COX-2. It is one of the major catabolic mediators involved in cartilage degradation and chondrocyte apoptosis [26]. The water extract of CC was earlier shown to decrease PGE2 production by almost 34% at 100 µg/ml concentration in RAW 264.7 cells, [25] whereas our study showed almost 80% reduction in PGE2 production at the same concentration of the extract. Moreover, we have analysed the effect of the extracts on PGE2 production in SWI353 and primary chondrocytes as well. OA cartilage spontaneously releases more PGE2 than the normal cartilage [27, 28]. Thus, blocking of PGE2 production by cinnamon in OA could be a promising strategy in preventing cartilage degradation and chondrocyte apoptosis.
In SW1353, the methanolic extracts of CC and CZ reduced LTB4 levels more effectively than the aqueous extracts. In primary human chondrocytes, CCW, CCM induced an enhanced decrease in LTB4 levels that went below the basal values and hence needs careful evaluation. Since LTB4 is involved in a number of important cellular processes in the body [29] and its down regulation below the basal level may lead to severe complications [30-32].
However, CZM effectively reduced LTB4 levels than CCW. Thus, CZ appears to be better option than CC in terms of LTB4 inhibition as it does not reduce LTB4 below the basal values. LTB4 plays a direct role in OA pathogenesis. Its increased synthesis has been found in the synovial tissue and synovial fluid of patients with OA. Thus, reducing LTB4 production in OA could help in modulating the pathophysiological conditions associated with this disease.
CCM and CZM effectively decreased the levels of MMPs 2, 9 and 13 compared to CCW, CZW. In human chondrocytes, MMPs are synthesized and secreted by chondrocytes in response to cytokines. The expression of gelatinases (MMP-2 and MMP-9) is either low or absent in most normal tissues, and markedly elevated during inflammation [33]. MMP-13 is secreted by chondrocytes in response to cytokines (IL-1β), causing digestion of type II collagen in cartilage [34]. It has also been reported to be associated with cartilage hypertrophy and calcification [35]. Thus, modulating the expression of MMPs 2, 9 and 13 by CCM and CZM could prevent continued degradation of articular cartilage.
Compared to the aqueous extracts of cinnamon, the methanolic extracts significantly reduced the production of NO, PGE2, LTB4 and MMPs. C. cassia has been reported to contain high amounts of coumarins, which may cause liver damage [36] whereas C. zeylanicum hardly contains any coumarin [36]. On comparing the two species of cinnamon, C. zeylanicum appears be a better modifier of the inflammatory cascade in OA related pathology. Thus, CZM could be proposed for its use in the modulation of major inflammatory mediators in OA, which would help in the regulation of chondrocyte survival, production of pro-inflammatory cytokines, prostaglandins, leukotrienes and production of ECM degrading enzymes such as MMPs.
In conclusion, these results suggested that compared to CC, CZ exhibited excellent anti-inflammatory activity through suppression of NO, PGE2, LTB4 and MMP production. Due to the serious side-effects associated with the use of NSAIDs, the focus of drug industries has shifted towards towards evaluation of anti-inflammatory activity of medicinal plants that are rich in phytochemicals. The search for natural products that would regulate the inflammatory cascade associated with OA without affecting chondrocytes survival is of pivotal importance. This work is a small step towards comparing the natural products that would not only be effective in managing OA but would also be safe for chondrocyte health, which in turn would protect the degradation of cartilage.
The authors would like to acknowledge Department of Biotechnology (DBT), Government of India, for funding the project (BT/PR10467/PBD/17/561/2008).
CONFLICT OF INTERESTS
The authors declare no conflict of interest.
REFERENCES